Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04835493 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evaluating Telementoring for CHW-centered Diabetes Initiatives

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Results posted: Oct 14, 2026 Show 4 more changesShow less
    • Primary endpoint revised
    • Eligibility criteria expanded, about 8 words
    • Secondary endpoints: 16 to 10
    • Publications: details revised at 3 of 3 entries
  2. Primary completion moved earlier from May 1, 2028 to Apr 30, 2025v15
  3. Primary completion pushed from Jul 31, 2026 to May 1, 2028
    • Study completion pushed from Jul 31, 2028 to Dec 31, 2028
    v14
  4. 2 versions Re-verified since May 27, 2025, no change to tracked fieldsv12-v13
  5. Trial status: Recruiting to Active, Not Recruiting
    • Site details revised
    v11
Show 9 earlier versionsHide 9 earlier versions
  1. Enrollment target: 250 to 320
    • Secondary endpoints revised (16)
    • Study description shortened, about 9 words
    • Study site revised
    v10
  2. Re-verified, no change to tracked fieldsv9
  3. Lead sponsor: Baylor College of Medicine to The University of Texas Medical Branch, Galveston
    • Secondary endpoints revised (16)
    • Collaborators: 3 to 4
    v8
  4. Re-verified, no change to tracked fieldsv7
  5. Trial status: Not Yet Recruiting to Recruitingv6 Show 4 more changesShow less
    • Primary completion date: Jun 30, 2026 to Jul 31, 2026
    • Study completion date: Aug 30, 2027 to Jul 31, 2028
    • Eligibility criteria expanded, about 14 words
    • Collaborators expanded, about 14 words
  6. Start date: Aug 1, 2022 to Sep 1, 2022
    • Study completion date: Jun 30, 2026 to Aug 30, 2027
    v5
  7. Start date: Jul 1, 2021 to Aug 1, 2022v4
  8. Re-verified, no change to tracked fieldsv3
  9. Secondary endpoints revised (16)
    • Study description shortened, about 1 word
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Diabetes care is complex and requires a multidimensional approach, but interventional programs are difficult to initiate in low-income and minority populations. In the proposed study, investigators will mentor local clinics via telehealth to initiate our diabetes program involving telehealth-support, integrated CHWs, medication-access, and diabetes Education into their clinics. Mentoring local clinics to initiate this intervention is a promising strategy to enhance sustainable diabetes care and reduce disparities in vulnerable minority populations.
Trial Details
NCT Number NCT04835493
Lead Sponsor The University of Texas Medical Branch, Galveston
Collaborators: The University of Texas Health Science Center, Houston, University of Houston, Baylor College of Medicine, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions
(from sponsor)		 Diabetes Mellitus, Type 2
Related terms Diabetes Mellitus, Type 2
Enrollment 320 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov